Search for: "Abbott Laboratories, Inc."
Results 81 - 100
of 450
Sorted by Relevance
|
Sort by Date
27 May 2009, 5:38 am
The new decision, Abbott Laboratories v. [read post]
8 Jan 2013, 11:23 am
Abbott Laboratories, Johnson & Johnson and Sanofi have reportedly shown interest in the company. [read post]
23 May 2022, 2:53 pm
After holding sales and management positions with such companies as Spectranetics, Abbott Laboratories and Marriott International, Inc., he served as ... [read post]
18 Apr 2014, 9:23 am
Motion Filed to Consolidate AndroGel Testosterone Therapy Lawsuits On March 28th, plaintiffs filed a motion to consolidate all lawsuits against AndroGel, manufactured by AbbVie Inc and Abbott Laboratories, into one multidistrict litigation (MDL). [read post]
4 Mar 2007, 5:47 pm
Abbott Laboratories v. [read post]
10 Jun 2014, 7:29 am
AndroGel Testosterone Therapy Lawsuits Consolidated The Judicial Panel on Multidistrict Litigation (JPML) issued an order on June 6th to consolidate testosterone therapy injury lawsuits involving Abbott Laboratories and Abbvie, Inc testosterone gels. [read post]
2 Jul 2009, 6:32 am
The jury found that Abbott Laboratories’ arthritis drug, Humira ® (adalimumab), infringed U.S. [read post]
1 Apr 2007, 4:46 pm
Abbott Laboratories et. al. v. [read post]
4 Jan 2017, 6:44 am
The settlement resolved multi-year litigation originally brought by private whistleblowers as a qui tam lawsuit under the False Claims Act (FCA), centered on claims that Omnicare had violated anti-kickback laws in its dealings with Abbott Laboratories, a multinational pharmaceutical company. [read post]
8 May 2007, 5:11 am
("Teva") from selling a generic version of plaintiff Abbott Laboratories' ("Abbott") antibiotic cefdinir, which it markets using the name Omnicef. [read post]
21 Oct 2008, 8:37 pm
Earlier today, October 21, 2008, the United States Court of Appeals for the Federal Circuit issued a decision in Abbott Laboratories v. [read post]
21 Oct 2008, 8:37 pm
Earlier today, October 21, 2008, the United States Court of Appeals for the Federal Circuit issued a decision in Abbott Laboratories v. [read post]
14 Aug 2006, 6:25 pm
The drug, sold by Abbott Laboratories, Inc., under the brand name Depakote, was found to be substantially riskier than any of the other three main epilepsy available on the market. [read post]
28 Apr 2010, 9:59 pm
(formerly Therasense, Inc.) and Abbott Laboratories; requested a response from Defendants-Appellees Becton, Dickinson & Co., Nova Biomedical Corp., and Bayer Healthcare LLC; granted Plaintiffs-Appellants leav to file a reply; and granted the Washington Legal Foundation, Nine Intellectual Property Law Professors, Hon. [read post]
10 Oct 2007, 8:29 pm
In Abbott Laboratories v. [read post]
20 Oct 2009, 7:28 pm
Abbott Nutrition, a division of Abbott Laboratories Inc., and Hospira Inc., have reported 122 incidents of fires, sparks or charring from power cords used with their devices, which include infusion pumps and adult feeding tubes. [read post]
26 Oct 2011, 7:40 am
Abbott Medical Optics, Inc v Alcon Laboratories, Inc [2011] APO 79 (26 September 2011) Opposition – novelty – whether claimed method anticipated by prior published instructions and prior use where benefits of method previously unrecognised – whether ‘strict proof’ of prior use required This decision, issued by Delegate Dr B. [read post]
20 Dec 2021, 4:48 am
Our firm is currently looking into potential Similac lawsuits against the formula manufacturer, Abbott Laboratories Inc., for failure to warn about the risks of NEC associated with Similac. [read post]
18 Jan 2017, 10:54 am
Abbott Laboratories Inc. [read post]
15 May 2012, 8:55 am
“Global Health Care Company Abbott Laboratories Inc. has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability arising from the company’s unlawful promotion of the prescription drug Depakote for uses not approved as safe and effective by the Food and Drug Administration (FDA), the Justice Department announced today. [read post]